首页> 外文期刊>Journal of Clinical and Diagnostic Research >Glycated Haemoglobin: Is it a Better Reference Method than Oral Glucose Tolerance Test for the Diagnosis of Gestational Diabetes Mellitus?
【24h】

Glycated Haemoglobin: Is it a Better Reference Method than Oral Glucose Tolerance Test for the Diagnosis of Gestational Diabetes Mellitus?

机译:糖化血红蛋白:是否比口服葡萄糖耐量试验更好的参考方法,用于诊断妊娠期糖尿病的妊娠期尿素?

获取原文
           

摘要

Insulin resistance during pregnancy is associated with adverse effects on foetal and maternal health, including macrosomia, congenital malformations, perinatal mortality and pre-eclampsia. A 100 g Oral Glucose Tolerance Test (OGTT) is recommended by World Health Organisation (WHO) as the diagnostic test for Gestational Diabetes Mellitus (GDM). However, the inconvenience caused to the pregnant females due to time consuming and cumbersome multi-invasive procedure for performing OGTT has prompted the exploration of an alternative method.Aim: To ascertain whether Glycated Haemoglobin (HbA1c) can be used instead of OGTT for diagnosis of GDM. Materials and Methods: It was a case-control study which was conducted for one year from June 2012 to May 2013. In this study, 200 pregnant females with gestational age from 22-40 weeks underwent Fasting Blood Sugar (FBS), Glucose Challenge Test (GCT) with 50 g glucose load, OGTT and HbA1c investigations.Results: The mean HbA1c of Group 1 with GDM was 5.29±0.68% and mean HbA1c of Group 2 without GDM was 4.83±0.46%. At the HbA1c cut-off of ≥5.85%, 18% of GDM patients were identified with specificity of 97%. A higher HbA1c cut-off of ≥5.95% showed sensitivity and specificity of 16.3% and 70%, respectively. An arbitrary cut-off of ≥5.85% would have diagnosed only 18% of patients with GDM with reasonable specificity. According to this study, 88% of GDM cases stayed undiagnosed by HbA1c at a cut-off of ≥5.85%. Hence, it can play only a supplemental role to OGTT in diagnosing GDM.Conclusion: On the basis of the present study, HbA1c can be used as a supplemental investigation in addition to OGTT for confirmation of GDM in pregnant females. Only drawback was the lack of fixed HbA1c cut-off for diagnosing GDM.
机译:妊娠期间的胰岛素抵抗与胎儿和孕产妇健康的不良反应有关,包括麦克罗塞诺,先天性畸形,围产期死亡率和预兴普氏症。世界卫生组织(世卫组织)建议使用100克口服葡萄糖耐量试验(OGTT)作为妊娠期糖尿病(GDM)的诊断测试。然而,由于耗时和繁琐的多侵入性程序对孕ogtt造成的孕妇引起的不便促使探索替代方法。探索:确定是否可以使用糖化血红蛋白(HBA1c)代替OGTT进行诊断GDM。材料和方法:这是一个案例对照研究,该研究于2012年6月至2013年5月进行了一年。在本研究中,200名怀孕女性,妊娠期22-40周的孕龄患者营养血糖(FBS),葡萄糖攻击试验(GCT)具有50g葡萄糖载荷,OGTT和HBA1C调查。结果:具有GDM的第1组的平均HBA1C为5.29±0.68%,并且2组的平均HBA1C没有GDM为4.83±0.46%。在HBA1C截止值≥5.85%,18%的GDM患者被鉴定为97%的特异性。 ≥5.95%的较高的HBA1C截止值显示出敏感性和特异性为16.3%和70%。任意截止≥5.85%将仅诊断为18%的GDM患者,具有合理的特异性。根据本研究,88%的GDM案例在截止值≥5.85%时,HBA1C停留了88%。因此,它可以仅在诊断GDM中对OGTT进行补充作用。结论:在本研究的基础上,除了ogtt以确认怀孕女性的ogtt之外,HBA1c还可以用作补充研究。只有缺点是缺乏固定的HBA1C截止,用于诊断GDM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号